Home » US Radioactive Drug Guidance Draws Line Between Basic Human, Clinical Research
US Radioactive Drug Guidance Draws Line Between Basic Human, Clinical Research
August 16, 2010
Sponsors of radioactive drugs or biologics do not need an investigational new drug (IND) approval to conduct basic human research in the U.S., but such studies do require approval from a Radioactive Drug Research Committee (RDRC), according to a final guidance.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor